• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Interleukin-27 subunit beta (Ebi3),Truncated

The process for producing recombinant Human EBI3 protein in e.coli cells follows a sequence of steps: creating the expression vector that codes for the Human EBI3 protein (21-227aa), introducing it into e.coli cells, cultivating and inducing of positive cells for protein expression, lysing cells, and conducting expression analysis. The resultant recombinant Human EBI3 protein is purified from the cell lysate using affinity purification, with its purity exceeding 85%, as determined by SDS-PAGE.

ACP01954

The process for producing recombinant Human EBI3 protein in e.coli cells follows a sequence of steps: creating the expression vector that codes for the Human EBI3 protein (21-227aa), introducing it into e.coli cells, cultivating and inducing of positive cells for protein expression, lysing cells, and conducting expression analysis. The resultant recombinant Human EBI3 protein is purified from the cell lysate using affinity purification, with its purity exceeding 85%, as determined by SDS-PAGE.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01954 Target NameEBI3
Target SynonymsIL-27 subunit beta;IL-27B;Epstein-Barr virus-induced gene 3 protein homologFormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range21-227aa
Mol Weight54.6 kDaProtein LengthPartial
PurityGreater than 85% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ14213
Background Information
  • Uniprot Id

    Q14213

  • Target Species

    Human

  • Target Name

    EBI3

  • Target Full Name

    Interleukin-27 subunit beta

  • Target Function

    Associates with IL27 to form the IL-27 interleukin, a heterodimeric cytokine which functions in innate immunity. IL-27 has pro- and anti-inflammatory properties, that can regulate T-helper cell development, suppress T-cell proliferation, stimulate cytotoxic T-cell activity, induce isotype switching in B-cells, and that has diverse effects on innate immune cells. Among its target cells are CD4 T-helper cells which can differentiate in type 1 effector cells (TH1), type 2 effector cells (TH2) and IL17 producing helper T-cells (TH17). It drives rapid clonal expansion of naive but not memory CD4 T-cells. It also strongly synergizes with IL-12 to trigger interferon-gamma/IFN-gamma production of naive CD4 T-cells, binds to the cytokine receptor WSX-1/TCCR. Another important role of IL-27 is its antitumor activity as well as its antiangiogenic activity with activation of production of antiangiogenic chemokines.

  • Target Subcellular Location

    Secreted.

  • Target Protein Families

    Type I cytokine receptor family, Type 3 subfamily

  • Target Research Area

    Immunology

  • Target Synonyms

    IL-27 subunit beta;IL-27B;Epstein-Barr virus-induced gene 3 protein homolog

  • Target Background

    This gene was identified by its induced expression in B lymphocytes in response Epstein-Barr virus infection. It encodes a secreted glycoprotein belonging to the hematopoietin receptor family, and heterodimerizes with a 28 kDa protein to form interleukin 27 (IL-27). IL-27 regulates T cell and inflammatory responses, in part by activating the Jak/STAT pathway of CD4+ T cells.

Inquire Recombinant Human Interleukin-27 subunit beta (Ebi3),Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification